Sort   by:  
 Page size 
TranscriptomicsTranscriptional profile of PBMCs from type 1 diabetes patients treated with low-dose human interleukin-2
Type 1 diabetes patients received a daily subcutaneous injection of placebo or 0.33, 1 or 3 Millions IU of interleukin-2 (IL-2) for 5 consecutive days. Transcriptomic analysis was performed on PBMCs collected from patients before and after the IL-2 course.
ORGANISM(S): Homo sapiens 
2015-06-30 | E-MTAB-2858 | biostudies-arrayexpress
TranscriptomicsRestoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation
Systemic lupus erythematosus (SLE) is a T and B cell-dependent autoimmune disease characterized by the appearance of autoantibodies, a global regulatory T cells (Tregs) depletion and an increase in Th17 cells. Recent studies have shown the multifaceted immunomodulatory effects of vitamin D, notably ...
ORGANISM(S): Homo sapiens 
2012-03-29 | E-GEOD-36941 | biostudies-arrayexpress
Sort   by:  
 Page size